Skip to Content

Exforge HCT Approval History

  • FDA approved: Yes (First approved April 30th, 2009)
  • Brand name: Exforge HCT
  • Generic name: amlodipine, valsartan and hydrochlorothiazide
  • Dosage form: Tablets
  • Company: Novartis AG
  • Treatment for: High Blood Pressure

Exforge HCT is a combination of the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide indicated for the once-daily combination treatment of hypertension.

Development History and FDA Approval Process for Exforge HCT

Apr 30, 2009Approval FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.